Top 100 Contractors in NAICS 3254: Pharmaceutical and Medicine Manufacturing, FY2024

Parent companies by net contract obligations Oct 1, 2023 – Sep 30, 2024 Code page on GovTribe

The top 10 won 87% of FY2024 NAICS 3254 contract dollars

Ranking facts

Contract obligations
$15,472,949,835 Net of deobligations, by contracts coded NAICS 3254 or a code under it
Contractors
724 Parent companies with an obligation
Largest contractor
McKesson Corporation $8.38 billion, 50.7% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $8,381,955,283
Rank history: #2 in FY2021, #2 in FY2022, #1 in FY2023 and #1 in FY2025; unchanged since FY2023.
2 $2,944,700,402
Rank history: #8 in FY2021, #14 in FY2022, #4 in FY2023 and #2 in FY2025; up 2 since FY2023.
3 $1,172,019,864
Rank history: not on the FY2021 list, #30 in FY2022, #3 in FY2023 and not on the FY2025 list; unchanged since FY2023.
4 $501,155,622
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
5
Roche Diabetes Care Inc 2 awardees, including Genentech Usa, Inc.
$397,452,959
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; up 96 since FY2023.
6 $270,999,520
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
7 $222,920,840
Rank history: #13 in FY2021, #15 in FY2022, #12 in FY2023 and #5 in FY2025; up 5 since FY2023.
8 $153,754,433
Rank history: not on the FY2021–FY2023 lists and #55 in FY2025; new.
9 $122,975,784
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
10 $120,957,530
Rank history: not on the FY2021–FY2023 lists and #4 in FY2025; new.
11 $91,119,397
Rank history: not on the FY2021 list, #19 in FY2022, #20 in FY2023 and #33 in FY2025; up 9 since FY2023.
12 $82,620,000
Rank history: #24 in FY2021, #21 in FY2022, #15 in FY2023 and #7 in FY2025; up 3 since FY2023.
13 $69,164,064
Rank history: not on the FY2021–FY2023 lists and #10 in FY2025; new.
14 $62,771,813
Rank history: #9 in FY2021, #7 in FY2022, #63 in FY2023 and #20 in FY2025; up 49 since FY2023.
15
Alvogen Group Inc. Through Alvogen, Inc.
$57,099,988
Rank history: not on the FY2021–FY2023 lists and #3 in FY2025; new.
16 $50,952,878
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; up 409 since FY2023.
17
Meridian Medical Technologies LLC
$39,095,170
Rank history: not on the FY2021–FY2023 lists and #12 in FY2025; new.
18 $35,030,992
Rank history: not on the FY2021–FY2023 lists and #13 in FY2025; new.
19 $34,040,200
Rank history: #20 in FY2021, #24 in FY2022, #28 in FY2023 and #23 in FY2025; up 9 since FY2023.
20 $32,713,775
Rank history: not on the FY2021–FY2023 lists and #14 in FY2025; new.
21 $29,873,987
Rank history: #30 in FY2021, #33 in FY2022, #24 in FY2023 and #17 in FY2025; up 3 since FY2023.
22 $29,523,264
Rank history: #16 in FY2021, #17 in FY2022, #11 in FY2023 and #15 in FY2025; down 11 since FY2023.
23 $28,180,072
Rank history: not on the FY2021 list, #46 in FY2022, #31 in FY2023 and #19 in FY2025; up 8 since FY2023.
24 $26,790,542
Rank history: not on the FY2021–FY2023 lists and #26 in FY2025; new.
25 $26,640,809
Rank history: not on the FY2021 list, #57 in FY2022, not on the FY2023 list and not on the FY2025 list; returned.
26 $25,953,134
Rank history: #29 in FY2021, #22 in FY2022, #22 in FY2023 and #27 in FY2025; down 4 since FY2023.
27 $25,692,481
Rank history: #28 in FY2021, not on the FY2022–FY2023 lists and #37 in FY2025; returned.
28 $24,227,222
Rank history: #58 in FY2021, #58 in FY2022, #35 in FY2023 and not on the FY2025 list; up 7 since FY2023.
29 $23,101,995
Rank history: #22 in FY2021, #37 in FY2022, #47 in FY2023 and not on the FY2025 list; up 18 since FY2023.
30 $22,201,974
Rank history: not on the FY2021 list, #25 in FY2022, #34 in FY2023 and #16 in FY2025; up 4 since FY2023.
31 $16,289,583
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
32 $15,108,791
Rank history: #34 in FY2021, #38 in FY2022, #39 in FY2023 and not on the FY2025 list; up 7 since FY2023.
33 $14,958,069
Rank history: #59 in FY2021, #55 in FY2022, not on the FY2023 list and not on the FY2025 list; returned.
34 $14,828,479
Rank history: #32 in FY2021, #9 in FY2022, #13 in FY2023 and not on the FY2025 list; down 21 since FY2023.
35 $13,696,432
Rank history: #31 in FY2021, #39 in FY2022, #32 in FY2023 and not on the FY2025 list; down 3 since FY2023.
36 $12,969,775
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
37 $11,190,536
Rank history: not on the FY2021–FY2023 lists and #31 in FY2025; new.
38 $10,486,221
Rank history: not on the FY2021–FY2023 lists and #44 in FY2025; new.
39 $10,112,508
Rank history: not on the FY2021–FY2023 lists and #42 in FY2025; up 191 since FY2023.
40 $10,091,475
Rank history: not on the FY2021 list, #48 in FY2022, #60 in FY2023 and not on the FY2025 list; up 20 since FY2023.
41 $9,611,321
Rank history: #42 in FY2021, #47 in FY2022, #55 in FY2023 and #83 in FY2025; up 14 since FY2023.
42 $8,375,000
Rank history: not on the FY2021–FY2023 lists and #47 in FY2025; new.
43 $8,133,605
Rank history: #38 in FY2021, #56 in FY2022, #41 in FY2023 and not on the FY2025 list; down 2 since FY2023.
44 $7,933,411
Rank history: not on the FY2021 list, #53 in FY2022, #46 in FY2023 and not on the FY2025 list; up 2 since FY2023.
45 $7,884,513
Rank history: not on the FY2021–FY2023 lists and #43 in FY2025; up 76 since FY2023.
46
Boehringer Ingelheim Animal Health USA Inc
$7,683,804
Rank history: not on the FY2021–FY2022 lists, #61 in FY2023 and #38 in FY2025; up 15 since FY2023.
47 $7,495,052
Rank history: not on the FY2021–FY2023 lists and #18 in FY2025; new.
48 $7,183,100
Rank history: #53 in FY2021, not on the FY2022 list, #43 in FY2023 and #8 in FY2025; down 5 since FY2023.
49 $6,467,147
Rank history: #55 in FY2021, #11 in FY2022, #54 in FY2023 and not on the FY2025 list; up 5 since FY2023.
50 $6,103,808
Rank history: #56 in FY2021, #54 in FY2022, #45 in FY2023 and #52 in FY2025; down 5 since FY2023.
51
Teva Pharmaceutical Industries Ltd. Through Teva Pharmaceuticals Usa, Inc.
$5,802,481
Rank history: #26 in FY2021, #32 in FY2022, #25 in FY2023 and not on the FY2025 list; down 26 since FY2023.
52 $5,350,258
Rank history: #52 in FY2021, #62 in FY2022, #53 in FY2023 and #97 in FY2025; up 1 since FY2023.
53 $5,335,318
Rank history: not on the FY2021–FY2023 lists and #35 in FY2025; new.
54 $5,186,280
Rank history: #90 in FY2021, #67 in FY2022, not on the FY2023 list and not on the FY2025 list; returned.
55 $4,147,309
Rank history: #79 in FY2021, #94 in FY2022, #58 in FY2023 and #45 in FY2025; up 3 since FY2023.
56 $3,767,731
Rank history: not on the FY2021 list, #85 in FY2022, #69 in FY2023 and #48 in FY2025; up 13 since FY2023.
57
Walgreens Boots Alliance Inc. Through Walgreen Co.
$3,700,561
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
58 $3,673,777
Rank history: #67 in FY2021, #96 in FY2022, #51 in FY2023 and not on the FY2025 list; down 7 since FY2023.
59 $3,664,624
Rank history: #65 in FY2021, #66 in FY2022, #49 in FY2023 and #41 in FY2025; down 10 since FY2023.
60 $3,663,360
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
61 $3,647,635
Rank history: #82 in FY2021, #41 in FY2022, #23 in FY2023 and not on the FY2025 list; down 38 since FY2023.
62 $3,464,292
Rank history: #71 in FY2021, #59 in FY2022, #52 in FY2023 and not on the FY2025 list; down 10 since FY2023.
63 $3,133,081
Rank history: not on the FY2021–FY2023 lists and #39 in FY2025; new.
64 $3,106,500
Rank history: not on the FY2021–FY2023 lists and #60 in FY2025; up 66 since FY2023.
65 $3,103,007
Rank history: #69 in FY2021, #68 in FY2022, #66 in FY2023 and not on the FY2025 list; up 1 since FY2023.
66 $2,999,778
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
67 $2,929,036
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; up 85 since FY2023.
68 $2,907,345
Rank history: #66 in FY2021, #60 in FY2022, #56 in FY2023 and #40 in FY2025; down 12 since FY2023.
69 $2,884,593
Rank history: not on the FY2021 list, #88 in FY2022, #79 in FY2023 and not on the FY2025 list; up 10 since FY2023.
70 $2,647,181
Rank history: #92 in FY2021, #79 in FY2022, #80 in FY2023 and #65 in FY2025; up 10 since FY2023.
71 $2,638,662
Rank history: #49 in FY2021, #64 in FY2022, #67 in FY2023 and #63 in FY2025; down 4 since FY2023.
72 $2,612,304
Rank history: #99 in FY2021, #70 in FY2022, #65 in FY2023 and #64 in FY2025; down 7 since FY2023.
73 $2,589,730
Rank history: not on the FY2021–FY2023 lists and #57 in FY2025; new.
74 $2,515,490
Rank history: #88 in FY2021, #78 in FY2022, #76 in FY2023 and not on the FY2025 list; up 2 since FY2023.
75 $2,406,377
Rank history: #14 in FY2021, #40 in FY2022, #42 in FY2023 and not on the FY2025 list; down 33 since FY2023.
76 $2,400,000
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
77 $2,285,657
Rank history: not on the FY2021–FY2022 lists, #83 in FY2023 and not on the FY2025 list; up 6 since FY2023.
78 $2,241,168
Rank history: #81 in FY2021, not on the FY2022 list, #77 in FY2023 and not on the FY2025 list; down 1 since FY2023.
79 $2,153,497
Rank history: #93 in FY2021, #89 in FY2022, #88 in FY2023 and #99 in FY2025; up 9 since FY2023.
80 $2,121,714
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
81 $2,107,056
Rank history: not on the FY2021–FY2023 lists and #28 in FY2025; new.
82 $2,075,263
Rank history: #75 in FY2021, #81 in FY2022, #86 in FY2023 and #89 in FY2025; up 4 since FY2023.
83 $2,050,794
Rank history: #97 in FY2021, not on the FY2022–FY2023 lists and not on the FY2025 list; up 20 since FY2023.
84 $2,020,817
Rank history: not on the FY2021–FY2022 lists, #93 in FY2023 and not on the FY2025 list; up 9 since FY2023.
85 $2,010,827
Rank history: not on the FY2021–FY2023 lists and #92 in FY2025; new.
86 $1,983,924
Rank history: not on the FY2021–FY2022 lists, #70 in FY2023 and #77 in FY2025; down 16 since FY2023.
87 $1,975,190
Rank history: not on the FY2021–FY2022 lists, #87 in FY2023 and #96 in FY2025; unchanged since FY2023.
88 $1,953,828
Rank history: #39 in FY2021, #20 in FY2022, #62 in FY2023 and not on the FY2025 list; down 26 since FY2023.
89 $1,809,359
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; up 49 since FY2023.
90 $1,785,334
Rank history: not on the FY2021 list, #86 in FY2022, #85 in FY2023 and #59 in FY2025; down 5 since FY2023.
91 $1,718,915
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; up 65 since FY2023.
92 $1,688,407
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; up 24 since FY2023.
93 $1,685,029
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
94 $1,675,276
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; up 24 since FY2023.
95 $1,637,384
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
96 $1,626,028
Rank history: #72 in FY2021, #69 in FY2022, #71 in FY2023 and #72 in FY2025; down 25 since FY2023.
97 $1,623,093
Rank history: not on the FY2021–FY2023 lists and #54 in FY2025; new.
98 $1,576,807
Rank history: not on the FY2021–FY2022 lists, #96 in FY2023 and #75 in FY2025; down 2 since FY2023.
99 $1,546,626
Rank history: not on the FY2021–FY2023 lists and #32 in FY2025; new.
100 $1,537,487
Rank history: not on the FY2021–FY2023 lists and #95 in FY2025; new.
Show 75 more

100 of 724 contractors listed here. See the rest on GovTribe.

Rankings for the codes under NAICS 3254

Code Net obligations Largest contractor
32541 Pharmaceutical and Medicine Manufacturing $15,472,949,835 McKesson Corporation

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $16.5 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2024 ran Oct 1, 2023 – Sep 30, 2024. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2023. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2023 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 NAICS 3254 contractors in FY2024?

1. McKesson Corporation ($8.38B), 2. Cencora, Inc. ($2.94B), 3. Amerisourcebergen Corporation ($1.17B), 4. Advanced Technology International ($501M), 5. Roche Diabetes Care Inc ($397M), 6. Analytic Services Inc. ($271M), 7. Bavarian Nordic A / S ($223M), 8. Merck & Co. Inc. ($154M), 9. Emergent Biosolutions Canada Inc. ($123M), 10. Emergent Biosolutions Inc. ($121M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work